Singapore markets closed

MGNX Jan 2025 5.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
1.80000.0000 (0.00%)
At close: 12:05PM EDT
Full screen
Previous close1.8000
Open1.6000
Bid1.3000
Ask1.7000
Strike5.00
Expiry date2025-01-17
Day's range1.6000 - 1.8000
Contract rangeN/A
Volume2
Open interest85
  • GlobeNewswire

    MacroGenics to Participate in Upcoming Investor Conference

    ROCKVILLE, MD, June 11, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company's management will participate in the following investor conference this month: Goldman Sachs 45th Annual Global Healthcare Conference (Miami Beach). MacroGenics’ President & Chief Executive Officer, Scott Koenig, M.D., P

  • Simply Wall St.

    Shareholders in MacroGenics (NASDAQ:MGNX) are in the red if they invested three years ago

    This month, we saw the MacroGenics, Inc. ( NASDAQ:MGNX ) up an impressive 37%. But that doesn't change the fact that...

  • GlobeNewswire

    MacroGenics to Participate in Upcoming Investor Conferences

    ROCKVILLE, MD, May 13, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company's management will participate in the following investor conferences this month: The Citizens JMP Life Sciences Conference (New York). MacroGenics’ President & Chief Executive Officer, Scott Koenig, M.D., Ph.D., will parti